Skip to main content

Outset Medical, Inc.

OM
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001484612

In the last 90 days, Outset Medical, Inc. insiders filed 0 open-market purchases and 3 sales; 92 institutions reported holding it in 13F filings for Q2 2026, worth $59.8M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Outset Medical, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of OM: Q4 2023 compared with Q1 2024
MeasureQ4 2023Of which not filed for Q1 2024Q1 2024Change
Holders1401114−25
Shares53.0M20.2K50.5M−2.49M (−4.7%)
Value$286.8M$109.4K$112.1M−$174.7M (−60.9%)

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (10)

Institutions that held Outset Medical, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to OM in Q1 2024
InstitutionSharesValue% of portfolio
Connor, Clark & Lunn Investment Management Ltd.345,343$766.7K0.00%
AQR Capital Management LLC191,171$424.4K0.00%
Two Sigma Securities, LLC64,819$143.9K0.01%
SEI Investments Co27,273$60.5K0.00%
Point72 (DIFC) Ltd18,459$41.0K0.00%
Quantbot Technologies LP4,143$9.20K0.00%
Steward Partners Investment Advisory, LLC2,400$5.33K0.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC94$2080.00%
First Command Advisory Services, Inc.12$270.00%
CWM, LLC80$00.00%

Sold out (35)

Institutions that held Outset Medical, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Not filed for Q1 2024 yet (1)

Institutions that held Outset Medical, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding OM in Q4 2023 that haven't filed for Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
AtonRa Partners20,214$109.4K